Blue Path Capital Management, LLC Axonics, Inc. Transaction History
Blue Path Capital Management, LLC
- $162 Billion
- Q3 2024
A detailed history of Blue Path Capital Management, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Blue Path Capital Management, LLC holds 3,786 shares of AXNX stock, worth $266,723. This represents 0.16% of its overall portfolio holdings.
Number of Shares
3,786
Previous 3,786
-0.0%
Holding current value
$266,723
Previous $255 Million
3.53%
% of portfolio
0.16%
Previous 0.18%
Shares
4 transactions
Others Institutions Holding AXNX
# of Institutions
230Shares Held
42.5MCall Options Held
50.2KPut Options Held
165K-
Vanguard Group Inc Valley Forge, PA5.04MShares$355 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.34MShares$306 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.11MShares$149 Million6.8% of portfolio
-
Fil LTD Hamilton, D02.04MShares$144 Million0.14% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1.77MShares$125 Million2.93% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.46B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...